Difference between revisions of "Template:Adrenergic receptor modulators"
Jump to navigation
Jump to search
blackwiki>Vanished 45kd09la13 |
blackwiki>Vanished 45kd09la13 |
||
| Line 21: | Line 21: | ||
* [[Dopamine]] | * [[Dopamine]] | ||
* [[Ephedrine]] | * [[Ephedrine]] | ||
| − | * [[Epinephrine]] | + | * [[Epinephrine]] |
* [[Etilefrine]] | * [[Etilefrine]] | ||
* [[Ethylnorepinephrine]] | * [[Ethylnorepinephrine]] | ||
| Line 31: | Line 31: | ||
* [[Midodrine]] | * [[Midodrine]] | ||
* [[Naphazoline]] | * [[Naphazoline]] | ||
| − | * [[Norepinephrine]] | + | * [[Norepinephrine]] |
* [[Octopamine]] | * [[Octopamine]] | ||
* [[Oxymetazoline]] | * [[Oxymetazoline]] | ||
| Line 66: | Line 66: | ||
* [[Metazosin]] | * [[Metazosin]] | ||
* [[Monatepil]] | * [[Monatepil]] | ||
| − | * [[Moxisylyte]] | + | * [[Moxisylyte]] |
* [[Naftopidil]] | * [[Naftopidil]] | ||
* [[Nantenine]] | * [[Nantenine]] | ||
| Line 95: | Line 95: | ||
* [[Upidosin]] | * [[Upidosin]] | ||
* [[Urapidil]] | * [[Urapidil]] | ||
| − | * [[Zolertine]]<br/><small>* Note that many [[tricyclic antidepressant|TCAs]], [[tetracyclic antidepressants|TeCAs]], [[antipsychotic]]s, [[ergoline]]s, and some [[piperazine]]s like [[buspirone]] | + | * [[Zolertine]]<br/><small>* Note that many [[tricyclic antidepressant|TCAs]], [[tetracyclic antidepressants|TeCAs]], [[antipsychotic]]s, [[ergoline]]s, and some [[piperazine]]s like [[buspirone]] and [[trazodone]] all antagonize α<sub>1</sub>-adrenergic receptors as well, which contributes to their side effects such as [[orthostatic hypotension]].</small> |
| group2 = [[α2-adrenergic receptor|α<sub>2</sub>]] | | group2 = [[α2-adrenergic receptor|α<sub>2</sub>]] | ||
| Line 114: | Line 114: | ||
* [[Ephedrine]] | * [[Ephedrine]] | ||
* [[Ergotamine]] | * [[Ergotamine]] | ||
| − | * [[Epinephrine]] | + | * [[Epinephrine]] |
* [[Esproquin]] | * [[Esproquin]] | ||
* [[Etilefrine]] | * [[Etilefrine]] | ||
| Line 127: | Line 127: | ||
* [[Mivazerol]] | * [[Mivazerol]] | ||
* [[Naphazoline]] | * [[Naphazoline]] | ||
| − | * [[Norepinephrine]] | + | * [[Norepinephrine]] |
* [[Phenylpropanolamine]] | * [[Phenylpropanolamine]] | ||
* [[Piperoxan]] | * [[Piperoxan]] | ||
| Line 169: | Line 169: | ||
* [[Sunepitron]] | * [[Sunepitron]] | ||
* [[Tolazoline]] | * [[Tolazoline]] | ||
| − | * [[Yohimbine]]<br/><small>* Note that many [[atypical antipsychotic]]s and [[azapirone]]s like [[buspirone | + | * [[Yohimbine]]<br/><small>* Note that many [[atypical antipsychotic]]s and [[azapirone]]s like [[buspirone]] (via metabolite [[pyrimidinylpiperazine|1-PP]]) antagonize α<sub>2</sub>-adrenergic receptors as well.</small> |
| group3 = [[β-adrenergic receptor|β]] | | group3 = [[β-adrenergic receptor|β]] | ||
| Line 195: | Line 195: | ||
* [[Dopexamine]] | * [[Dopexamine]] | ||
* [[Ephedrine]] | * [[Ephedrine]] | ||
| − | * [[Epinephrine]] | + | * [[Epinephrine]] |
* [[Etafedrine]] | * [[Etafedrine]] | ||
* [[Etilefrine]] | * [[Etilefrine]] | ||
| Line 205: | Line 205: | ||
* [[Indacaterol]] | * [[Indacaterol]] | ||
* [[Isoetarine]] | * [[Isoetarine]] | ||
| − | * [[Isoprenaline]] | + | * [[Isoprenaline]] |
* [[Isoxsuprine]] | * [[Isoxsuprine]] | ||
* [[Labetalol]] | * [[Labetalol]] | ||
| Line 214: | Line 214: | ||
* [[Methyldopa]] | * [[Methyldopa]] | ||
* [[N-Isopropyloctopamine|''N''-Isopropyloctopamine]] | * [[N-Isopropyloctopamine|''N''-Isopropyloctopamine]] | ||
| − | * [[Norepinephrine]] | + | * [[Norepinephrine]] |
* [[Orciprenaline]] | * [[Orciprenaline]] | ||
* [[Oxyfedrine]] | * [[Oxyfedrine]] | ||
| Line 226: | Line 226: | ||
* [[Rimiterol]] | * [[Rimiterol]] | ||
* [[Ritodrine]] | * [[Ritodrine]] | ||
| − | * [[Salbutamol]] | + | * [[Salbutamol]] |
* [[Salmeterol]] | * [[Salmeterol]] | ||
* [[Solabegron]] | * [[Solabegron]] | ||
| Line 464: | Line 464: | ||
* [[Morazone]] | * [[Morazone]] | ||
* [[Phendimetrazine]] | * [[Phendimetrazine]] | ||
| − | * [[Phenmetrazine]]; ''Oxazolines'': [[4-Methylaminorex]] | + | * [[Phenmetrazine]]; ''Oxazolines'': [[4-Methylaminorex|4-MAR]] |
* [[Aminorex]] | * [[Aminorex]] | ||
* [[Clominorex]] | * [[Clominorex]] | ||
| Line 471: | Line 471: | ||
* [[Fluminorex]] | * [[Fluminorex]] | ||
* [[Pemoline]] | * [[Pemoline]] | ||
| − | * [[Thozalinone]]; ''Phenethylamines'' (also ''amphetamines'', ''cathinones | + | * [[Thozalinone]]; ''Phenethylamines'' (also ''amphetamines'', ''cathinones'', etc): [[2-Hydroxyphenethylamine|2-OH-PEA]] |
* [[4-Chlorophenylisobutylamine|4-CAB]] | * [[4-Chlorophenylisobutylamine|4-CAB]] | ||
* [[4-Fluoroamphetamine|4-FA]] | * [[4-Fluoroamphetamine|4-FA]] | ||
| Line 494: | Line 494: | ||
* [[Clobenzorex]] | * [[Clobenzorex]] | ||
* [[Clortermine]] | * [[Clortermine]] | ||
| − | |||
* [[Dimethylamphetamine]] | * [[Dimethylamphetamine]] | ||
| − | * [[Dimethylcathinone]] | + | * [[Dimethylcathinone]] |
* [[Dimethoxyamphetamine|DMA]] | * [[Dimethoxyamphetamine|DMA]] | ||
* [[Dimethoxymethamphetamine|DMMA]] | * [[Dimethoxymethamphetamine|DMMA]] | ||
| Line 511: | Line 510: | ||
* [[Furfenorex]] | * [[Furfenorex]] | ||
* [[Hordenine]] | * [[Hordenine]] | ||
| + | * [[Hydroxyamphetamine]] | ||
* [[Indanylaminopropane|IAP]] | * [[Indanylaminopropane|IAP]] | ||
* [[Indanylmethylaminopropane|IMP]] | * [[Indanylmethylaminopropane|IMP]] | ||
* [[Iofetamine]] | * [[Iofetamine]] | ||
| − | |||
* [[Lisdexamfetamine]] | * [[Lisdexamfetamine]] | ||
* [[Lophophine]] | * [[Lophophine]] | ||
* [[Methylbenzodioxolylbutanamine|MBDB]] | * [[Methylbenzodioxolylbutanamine|MBDB]] | ||
| − | * [[Methylenedioxyamphetamine|MDA]] | + | * [[Methylenedioxyamphetamine|MDA]] |
* [[Methylenedioxyethylamphetamine|MDEA]] | * [[Methylenedioxyethylamphetamine|MDEA]] | ||
* [[Methylenedioxymethamphetamine|MDMA]] | * [[Methylenedioxymethamphetamine|MDMA]] | ||
| Line 532: | Line 531: | ||
* [[Methedrone]] | * [[Methedrone]] | ||
* [[Methylone]] | * [[Methylone]] | ||
| − | * [[ | + | * [[Naphthylisopropylamine]] |
* [[Ortetamine]] | * [[Ortetamine]] | ||
| − | + | * [[Parabromoamphetamine|''p''BA]] | |
| − | * [[Parabromoamphetamine| | + | * [[Parachloroamphetamine|''p''CA]] |
| − | * [[Parachloroamphetamine| | + | * [[Pentorex]] |
| − | * [[Pentorex]] | ||
* [[Phenethylamine]] | * [[Phenethylamine]] | ||
* [[Pholedrine]] | * [[Pholedrine]] | ||
| Line 543: | Line 541: | ||
* [[Phentermine]] | * [[Phentermine]] | ||
* [[Phenylpropanolamine]] | * [[Phenylpropanolamine]] | ||
| − | * [[Paraiodoamphetamine| | + | * [[Paraiodoamphetamine|''p''IA]] |
* [[Prenylamine]] | * [[Prenylamine]] | ||
* [[Propylamphetamine]] | * [[Propylamphetamine]] | ||
* [[Pseudoephedrine]] | * [[Pseudoephedrine]] | ||
| + | * [[Selegiline]] (also [[D-Deprenyl|<small>D</small>-Deprenyl]]) | ||
* [[Tiflorex]] | * [[Tiflorex]] | ||
* [[Tyramine]] | * [[Tyramine]] | ||
* [[Xylopropamine]] | * [[Xylopropamine]] | ||
| − | * [[Zylofuramine]]; ''Piperazines'': [[ | + | * [[Zylofuramine]]; ''Piperazines'': [[2C-B-BZP]] |
* [[Benzylpiperazine|BZP]] | * [[Benzylpiperazine|BZP]] | ||
* [[Methylbenzylpiperazine|MBZP]] | * [[Methylbenzylpiperazine|MBZP]] | ||
| Line 556: | Line 555: | ||
* [[Methylenedioxybenzylpiperazine|MDBZP]] | * [[Methylenedioxybenzylpiperazine|MDBZP]] | ||
* [[Methoxyphenylpiperazine|MeOPP]] | * [[Methoxyphenylpiperazine|MeOPP]] | ||
| − | * [[Parafluorophenylpiperazine|pFPP]]; ''Others'': [[2-Amino-1,2-dihydronaphthalene]] | + | * [[Parafluorophenylpiperazine|pFPP]]; ''Others'': [[2-Amino-1,2-dihydronaphthalene|2-ADN]] |
| − | * [[2-Aminoindane]] | + | * [[2-Aminoindane|2-AI]] |
| − | * [[2-Aminotetralin]] | + | * [[2-Aminotetralin|2-AT]] |
| − | * [[2-Benzylpiperidine]] | + | * [[2-Benzylpiperidine|2-BP]] |
| − | * [[4-Benzylpiperidine]] | + | * [[4-Benzylpiperidine|4-BP]] |
* [[5-Iodo-2-aminoindane|5-IAI]] | * [[5-Iodo-2-aminoindane|5-IAI]] | ||
* [[Clofenciclan]] | * [[Clofenciclan]] | ||
| Line 660: | Line 659: | ||
* [[Clorgiline]] | * [[Clorgiline]] | ||
* [[Esuprone]] | * [[Esuprone]] | ||
| − | * [[Harmala alkaloid]]s ([[Harmine]] | + | * [[Harmala alkaloid]]s ([[Harmine]], |
* [[Harmaline]] | * [[Harmaline]] | ||
* [[Tetrahydroharmine]] | * [[Tetrahydroharmine]] | ||
* [[Harmala alkaloid#Chemical forms|Harman]] | * [[Harmala alkaloid#Chemical forms|Harman]] | ||
* [[Norharman]], etc) | * [[Norharman]], etc) | ||
| − | * [[Methylene blue | + | * [[Methylene blue]] |
* [[Metralindole]] | * [[Metralindole]] | ||
* [[Minaprine]] | * [[Minaprine]] | ||
| Line 673: | Line 672: | ||
* [[Tetrindole]] | * [[Tetrindole]] | ||
* [[Toloxatone]] | * [[Toloxatone]] | ||
| − | * [[Tyrima]]; ''MAO-B selective'': | + | * [[Tyrima]]; ''MAO-B selective'': |
| − | |||
* [[Ladostigil]] | * [[Ladostigil]] | ||
* [[Lazabemide]] | * [[Lazabemide]] | ||
| Line 681: | Line 679: | ||
* [[Pargyline]] | * [[Pargyline]] | ||
* [[Rasagiline]] | * [[Rasagiline]] | ||
| − | * [[Safinamide]]<br /><small>* Note that MAO-B inhibitors also influence norepinephrine/epinephrine levels since they inhibit the breakdown of their precursor dopamine.</small> | + | * [[Safinamide]] |
| + | * [[Selegiline]] (also [[<small>D</small>-Deprenyl]])<br /><small>* Note that MAO-B inhibitors also influence norepinephrine/epinephrine levels since they inhibit the breakdown of their precursor dopamine.</small> | ||
| group2 = [[Catechol O-methyl transferase|COMT]] | | group2 = [[Catechol O-methyl transferase|COMT]] | ||
| Line 723: | Line 722: | ||
* [[Guanclofine]] | * [[Guanclofine]] | ||
* [[Guanethidine]] | * [[Guanethidine]] | ||
| − | * [[Guanoxan]]; ''Toxins'': [[ | + | * [[Guanoxan]]; ''Toxins'': [[6-Hydroxydopamine|6-OHDA]] |
}} | }} | ||